HABA LABORATORIES (TSE:4925) Ending Cash Position: 円5,685 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4925 HABA LABORATORIES Inc TSE:4925
54 GF Score
Price 円1,735.00
GF Value 円1,966.64
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is HABA LABORATORIES Ending Cash Position?

HABA LABORATORIES TSE:4925 54 Ending Cash Position is 円5,685 Mil as of Mar. 2026. GuruFocus rates TSE:4925 with a GF Score™ of 54/100 and a GF Value™ of 円1,966.64 (Modestly Undervalued). The stock has 2 warning signs investors should review.

HABA LABORATORIES's Ending Cash Position for the quarter that ended in Mar. 2026 was 円5,685 Mil.

HABA LABORATORIES's quarterly Ending Cash Position increased from Sep. 2025 (円4,383 Mil) to Dec. 2025 (円4,825 Mil) and increased from Dec. 2025 (円4,825 Mil) to Mar. 2026 (円5,685 Mil).

HABA LABORATORIES's annual Ending Cash Position increased from Mar. 2024 (円3,959 Mil) to Mar. 2025 (円4,744 Mil) and increased from Mar. 2025 (円4,744 Mil) to Mar. 2026 (円5,685 Mil).

HABA LABORATORIES Ending Cash Position Related Terms

HABA LABORATORIES Ending Cash Position Historical Data

* Premium members only.

The historical data trend for HABA LABORATORIES's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HABA LABORATORIES Ending Cash Position Chart

HABA LABORATORIES Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,651.29 4,817.84 3,959.20 4,743.54 5,684.51

HABA LABORATORIES Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,477.93 4,382.91 4,824.57 5,684.51 5,146.67
TSE:4925
54GF Score
HABA LABORATORIES Inc TSE:4925
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HABA LABORATORIES Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

HABA LABORATORIES's Ending Cash Position for the fiscal year that ended in Mar. 2026 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=4743.538+940.969
=5,685

HABA LABORATORIES's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=5684.507+
=5,685

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of 円5,685 Mil mean?
HABA LABORATORIES (TSE:4925) has a Ending Cash Position of 円5,685 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on HABA LABORATORIES and its competitors.
Is HABA LABORATORIES's Ending Cash Position too high?
HABA LABORATORIES's current Ending Cash Position is 円5,685 Mil. Overall, HABA LABORATORIES has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does HABA LABORATORIES's Ending Cash Position compare to PG and CL?
HABA LABORATORIES's Ending Cash Position of 円5,685 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Consumer Packaged Goods company?
A good Ending Cash Position depends on the Consumer Packaged Goods industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on HABA LABORATORIES and its competitors. HABA LABORATORIES's current Ending Cash Position is 円5,685 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HABA LABORATORIES stock overvalued right now?
Based on GuruFocus' analysis, HABA LABORATORIES (TSE:4925) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,966.64, compared to a current price of 円1,735.00 — trading 11.8% below its estimated fair value. The current Ending Cash Position is 円5,685 Mil. HABA LABORATORIES's overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For HABA LABORATORIES (TSE:4925), the current Ending Cash Position is 円5,685 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HABA LABORATORIES (TSE:4925) Overvalued in 2026?

Based on GuruFocus' analysis, HABA LABORATORIES stock appears to be undervalued. The current stock price of 円1,735.00 is trading 11.8% below its estimated GF Value™ of 円1,966.64. GuruFocus considers HABA LABORATORIES to be Modestly Undervalued.

Key valuation signals for TSE:4925:

  • Ending Cash Position: 円5,685 Mil
  • GF Value™: 円1,966.64 vs. price of 円1,735.00 (11.8% below fair value)
  • GF Score™: 54/100 with 2 warning signs

No single metric tells the full story. See the TSE:4925 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HABA LABORATORIES Business Description

Address 1-24-11, Kanda Sudacho, Chiyoda-ku, Tokyo, JPN, 101 0041
HABA LABORATORIES Inc along with its subsidiaries develops, manufactures and distributes natural cosmetics, quasi-drugs and nutritional supplements. The company sells its products through shops, delivery centers, mail order, and the Internet.
54GF Score

Get the complete analysis for TSE:4925

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,735.00
Price
円1,966.64
GF Value